CONTACT: JENNIFER CRONIN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-5661; fax (319) 335-9917
Release: June 8, 1999
Individuals invited to participate in UI study on Parkinsons
IOWA CITY, Iowa University of Iowa researchers
are conducting a study on how a new medication may slow the progression of
Patients in the early stage of Parkinson's disease
are invited to participate. Individuals must have had disease symptoms for
less than three years and must not be taking any medication for their illness.
Participants will be randomly assigned to receive
either the drug or a placebo and will be treated and followed at regular intervals
for up to 26 months. There will be no charge to participate.
Persons interested in participating should contact
Judy Dobson at (319) 356-8958.
Robert L. Rodnitzky, M.D., UI professor of neurology,
will lead the study. The UI Hospitals and Clinics is one of 120 medical centers
in the United States, Canada and Europe that will test the drug. Rhone-Poulenc
Rorer of France is sponsoring the study.